Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose
- 1 December 1997
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 131 (6) , 888-893
- https://doi.org/10.1016/s0022-3476(97)70038-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Iv gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide surveyActa Paediatrica, 1995
- A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki diseasePediatrics International, 1994
- Diagnosis and therapy of Kawasaki disease in children.Circulation, 1993
- Intravenous γ‐Globulin Treatment in Kawasaki DiseasePediatrics International, 1991
- Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalitiesThe American Journal of Cardiology, 1991
- Treatment of Kawasaki syndrome: A comparison of two dosage regimens of intravenously administered immune globulinThe Journal of Pediatrics, 1990
- Clinical Trial of Single-Dose Intravenous Gamma Globulin in Acute Kawasaki DiseaseAmerican Journal of Diseases of Children, 1989
- High-dose gammaglobulin therapy for Kawasaki diseaseThe Journal of Pediatrics, 1987
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASEThe Lancet, 1984